🇺🇸 FDA
Patent

US 9962379

Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

granted A61KA61K31/135A61K31/137

Quick answer

US patent 9962379 (Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use) held by United States Government as represented by the Department of Veterans Affairs expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/135, A61K31/137, A61K31/138, A61K31/15